Current Management of Dupuytren's Contracture. A Practical Review
Main Article Content
Abstract
Dupuytren's contracture is a reasonably frequent condition characterized by palmar fascia fibrosis. It is a benign fibroproliferative disease of the palmar fascia that progresses slowly. The treatment aims are to restore finger mobility and to determine if surgery or other procedures are required. The therapy chosen is determined on the severity of the ailment. There are now many approaches for treating individuals with Dupuytren's contracture; each case must be carefully selected to provide the most benefit, limit morbidity, and avoid recurrences.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Mella, J. R., Guo, L., & Hung, V. (2018). Dupuytren’s contracture: An evidence based review. Annals of Plastic Surgery, 81(6S), S97-S101.
II. Nayar, S. K., Pfisterer, D., & Ingari, J. V. (2019). Collagenase clostridium histolyticum injection for Dupuytren contracture: 2-year follow-up. Clinics in orthopedic surgery, 11(3), 332-336.
III. Aglen, T., Matre, K. H., Lind, C., Selles, R. W., Aßmus, J., & Taule, T. (2019). Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial. BMC Musculoskeletal Disorders, 20(1), 1-14.
IV. Dutta, A., Jayasinghe, G., Deore, S., Wahed, K., Bhan, K., Bakti, N., & Singh, B. (2020). Dupuytren’s contracture–current concepts. Journal of Clinical Orthopaedics and Trauma, 11(4), 590-596.
V. Patel, M. I., & Patel, I. A. (2021). Versatility of percutaneous needle fasciotomy for Dupuytren's disease across a spectrum of disease severity: A single-surgeon experience of 118 rays. JPRAS open, 27, 80-89.
VI. Kitridis, D., Karamitsou, P., Giannaros, I., Papadakis, N., Sinopidis, C., & Givissis, P. (2019). Dupuytren’s disease: limited fasciectomy, night splinting, and hand exercises—long-term results. European Journal of Orthopaedic Surgery & Traumatology, 29(2), 349-355.
VII. Ruettermann, M., Hermann, R. M., Khatib-Chahidi, K., & Werker, P. M. (2021). Dupuytren’s Disease—Etiology and Treatment. Deutsches Ärzteblatt International, 118(46), 781.
VIII. Moog, P., Buchner, L., Cerny, M. K., Schmauss, D., Megerle, K., & Erne, H. (2019). Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren’s disease. Archives of Orthopaedic and Trauma Surgery, 139(10), 1471-1477.
IX. Selles, R. W., Zhou, C., Kan, H. J., Wouters, R. M., van Nieuwenhoven, C. A., & Hovius, S. E. (2018). Percutaneous aponeurotomy and lipofilling versus limited fasciectomy for Dupuytren’s contracture: 5-year results from a randomized clinical trial. Plastic and Reconstructive Surgery, 142(6), 1523-1531.
X. Nayar, S. K., Pfisterer, D., & Ingari, J. V. (2019). Collagenase clostridium histolyticum injection for Dupuytren contracture: 2-year follow-up. Clinics in orthopedic surgery, 11(3), 332-336.
XI. Boe, C., Blazar, P., & Iannuzzi, N. (2021). Dupuytren contractures: an update of recent literature. The Journal of Hand Surgery, 46(10), 896-906.
XII. Kaufman-Janette, J., Joseph, J. H., Kaminer, M. S., Clark, J., Fabi, S. G., Gold, M. H., ... & Bass, L. S. (2021). Collagenase clostridium histolyticum-aaes for the treatment of cellulite in women: results from two phase 3 randomized, placebo-controlled trials. Dermatologic Surgery, 47(5), 649.
XIII. DiFrancesco, T., Khanna, A., & Stubblefield, M. D. (2020, February). Clinical evaluation and management of cancer survivors with radiation fibrosis syndrome. In Seminars in Oncology Nursing (Vol. 36, No. 1, p. 150982). WB Saunders.